Early results spur hope for drug to stabilize Alzheimer's; a much bigger study will end soon

For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and in only four patients. The drug is Gammagard, made by Baxter International Inc....More